Literature DB >> 15977233

Serological and molecular studies on subclinical hepatitis E virus infection using periodic serum samples obtained from healthy individuals.

Takehiro Mitsui1, Yukie Tsukamoto, Shigeru Suzuki, Chikao Yamazaki, Kazuo Masuko, Fumio Tsuda, Masaharu Takahashi, Bira Tsatsralt-Od, Tsutomu Nishizawa, Hiroaki Okamoto.   

Abstract

Subclinical hepatitis E virus (HEV) infection among healthy individuals was studied serologically and molecularly. Serum samples collected at screening between March and April 2004 (or just before retirement) from 266 medical staff members (35 males, 231 females) who had been working for 8.8 +/- 8.5 (mean +/- standard deviation, range, 0.3-35.1) years in a city hospital in Japan and serum samples that had been collected from these staff members at the start of employment were tested for IgA, IgM, and IgG antibodies to HEV (anti-HEV) by in-house enzyme-linked immunosorbent assays. Overall, six subjects (2.3%) tested positive for anti-HEV IgG at the screening; among them, four subjects (1.5%) had already been positive for anti-HEV IgG at the start of employment and two subjects (0.8%) seroconverted after initiation of employment. Periodic serum samples that had been collected from the two seroconverted subjects were tested for HEV antibodies and HEV RNA. The two subjects became positive for anti-HEV IgG in 1978 or 2003, respectively, with no discernible elevation in alanine aminotransferase (ALT) level, and continued to be seropositive up through the screening date. Although anti-HEV IgM was not detectable in the two subjects, one was infected transiently with Japan-indigenous HEV strain of genotype 3 and the other was positive transiently for anti-HEV IgA. The present study indicates that even an individual with subclinical HEV infection had evidence of transient viremia in the absence of ALT elevation and that anti-HEV IgA detection may be useful for serological diagnosis of recent subclinical HEV infection. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15977233     DOI: 10.1002/jmv.20393

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

1.  Hepatitis E Virus.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

2.  Hepatitis E Virus.

Authors:  Georg Pauli; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Horst Klamm; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2008-01-18       Impact factor: 3.747

3.  Significance of serum IgA in patients with acute hepatitis E virus infection.

Authors:  De-Ying Tian; Yan Chen; Ning-Shao Xia
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

4.  Hepatitis E Virus.

Authors:  Georg Pauli; Martin Aepfelbacher; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Barbara Gärtner; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Uwe Schlenkrich; Volkmar Schottstedt; Rainer Seitz; Johanna Strobel; Hannelore Willkommen; Sally A Baylis
Journal:  Transfus Med Hemother       Date:  2015-06-01       Impact factor: 3.747

5.  Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt.

Authors:  Salwa S Seif Eldin; Ismail Seddik; Enas A Daef; M T Shata; Marwa Raafat; Laila Abdel Baky; M A Nafeh
Journal:  Egypt J Immunol       Date:  2010

6.  High hepatitis E virus seroprevalence in forestry workers and in wild boars in France.

Authors:  Audrey Carpentier; Hélène Chaussade; Emma Rigaud; Josefa Rodriguez; Camille Berthault; Franck Boué; Mauro Tognon; Antoine Touzé; Nathalie Garcia-Bonnet; Patrick Choutet; Pierre Coursaget
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

7.  The mystery of hepatitis E seroprevalence in developed countries: is there subclinical infection due to hepatitis E virus?

Authors:  Mohamed T Shata; Udayakumar Navaneethan
Journal:  Clin Infect Dis       Date:  2008-10-15       Impact factor: 9.079

8.  Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection.

Authors:  Abeer Elkady; Yasuhito Tanaka; Fuat Kurbanov; Noboru Hirashima; Masaya Sugiyama; Anis Khan; Hideaki Kato; Akihiko Okumura; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2007-11-22       Impact factor: 7.527

9.  Acute infection by hepatitis E virus with a slight immunoglobulin M antibody response.

Authors:  Yuki Inagaki; Yukio Oshiro; Mamiko Imanishi; Kazunori Ishige; Masaharu Takahashi; Hiroaki Okamoto; Nobuhiro Ohkohchi
Journal:  Clin J Gastroenterol       Date:  2015-07-28

10.  Clinical significance of anti-HEV IgA in diagnosis of acute genotype 4 hepatitis E virus infection negative for anti-HEV IgM.

Authors:  Shujun Zhang; Deying Tian; Zhengang Zhang; Junhui Xiong; Quan Yuan; Shengxiang Ge; Jun Zhang; Ningshao Xia
Journal:  Dig Dis Sci       Date:  2009-01-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.